FDG PET imaging of Ela1-myc mice reveals major biological differences between pancreatic acinar and ductal tumours

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 7, 2009, Pages 1156-1166

  Abasolo, Ibane ^a,b,c   Pujal, Judit ^a   Rabanal, Rosa M ^d   Serafin, Anna ^d   Navarro, Pilar ^a   Millán, Olga ^c   Real, Francisco X ^a,b,e  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c Institut d'Alta Tecnologia   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e Structural Biology and Biocomputing Programme   (Spain)

Author keywords

18F FDG; Glut proteins; Hexokinase; Pancreatic cancer; Positron emission tomography

Indexed keywords

AMYLASE; CARBOXYPEPTIDASE A; CYTOKERATIN 7; FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 3; GLUCOSE TRANSPORTER 4; GLUCOSE TRANSPORTER 5; HEXOKINASE; HEXOKINASE 1; HEXOKINASE ISOENZYME; MESSENGER RNA; TRANSMEMBRANE CONDUCTANCE REGULATOR; TUMOR MARKER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CANCER MODEL; CONTROLLED STUDY; EARLY DIAGNOSIS; EX VIVO STUDY; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LONGITUDINAL STUDY; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PALPATION; PANCREAS CANCER; PANCREATIC ACINAR TUMOR; PANCREATIC DUCTAL TUMOR; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RADIOACTIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; VALIDATION PROCESS;

ANIMALS; CARCINOMA, ACINAR CELL; CARCINOMA, PANCREATIC DUCTAL; FEMALE; FLUORODEOXYGLUCOSE F18; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HEXOKINASE; MALE; MICE; MICE, TRANSGENIC; POSITRON-EMISSION TOMOGRAPHY; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 67349225961     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1083-3     Document Type: Article

References (34)

1. EP DiMagno HA Reber MA Tempero 1999 AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association Gastroenterology 117 1464 1484
2. FX Real 2003 A "catastrophic hypothesis" for pancreas cancer progression Gastroenterology 124 1958 1964 (Pubitemid 36666791)
3. BB Chin PP Chang 2006 Gastrointestinal malignancies evaluated with (18)F-fluoro-2-deoxyglucose positron emission tomography Best Pract Res Clin Gastroenterol 20 3 21 (Pubitemid 43210624)
4. D Delbeke CW Pinson 2004 Pancreatic tumors: role of imaging in the diagnosis, staging, and treatment J Hepatobiliary Pancreat Surg 11 4 10 (Pubitemid 38404325)
5. S Aguilar JM Corominas N Malats JA Pereira M Dufresne FX Real 2004 Tissue plasminogen activator in murine exocrine pancreas cancer: selective expression in ductal tumors and contribution to cancer progression Am J Pathol 165 1129 1139 (Pubitemid 39297720)
6. EP Sandgren CJ Quaife AG Paulovich RD Palmiter RL Brinster 1991 Pancreatic tumor pathogenesis reflects the causative genetic lesion Proc Natl Acad Sci USA 88 93 97 (Pubitemid 21914433)
7. DJ Liao Y Wang J Wu NV Adsay D Grignon F Khanani 2006 Characterization of pancreatic lesions from MT-tgf alpha, Ela-myc and MT-tgf alpha/Ela-myc single and double transgenic mice J Carcinog 5 19
8. B Thorens 1992 Molecular and cellular physiology of Glut-2, a high-Km facilitated diffusion glucose transporter Int Rev Cytol 137 209 238
9. TAD Smith 2001 The rate-limiting step for tumor [18F]fluoro-2-deoxy-D- glucose (FDG) incorporation Nucl Med Biol 28 1 4 (Pubitemid 32155959)
10. I Hernández-Muñoz A Skoudy FX Real P Navarro 2008 Pancreatic ductal adenocarcinoma: cellular origin, signaling pathways and stroma contribution Pancreatology 8 462 469
11. EK Pauwels MJ Ribeiro JH Stoot VR [tmp] McCready M Bourguignon B Mazière 1998 FDG accumulation and tumor biology Nucl Med Biol 25 317 322 (Pubitemid 28219093)
12. ML Macheda S Rogers JD Best 2005 Molecular and cellular regulation of glucose transporter (Glut) proteins in cancer J Cell Physiol 202 654 662 (Pubitemid 40175840)
13. TA Smith 2000 Mammalian hexokinases and their abnormal expression in cancer Br J Biomed Sci 57 170 178 (Pubitemid 30417071)
14. B Nakata S Nishimura T Ishikawa M Ohira H Nishino J Kawabe 2001 Prognostic predictive value of 18F-fluorodeoxyglucose positron emission tomography for patients with pancreatic cancer Int J Oncol 19 53 58
15. M Zimny J Fass R Bares U Cremerius O Sabri P Buechin 2000 Fluorodeoxyglucose positron emission tomography and the prognosis of pancreatic carcinoma Scand J Gastroenterol 35 883 888 (Pubitemid 30687882)
16. U Seitz M Wagner AT Vogg G Glatting B Neumaier FR Greten 2001 In vivo evaluation of 5-[(18)F]fluoro-2?-deoxyuridine as tracer for positron emission tomography in a murine pancreatic cancer model Cancer Res 61 3853 3857 (Pubitemid 32720940)
17. AC Buck HH Schirrmeister CA Guhlmann CG Diederichs C Shen I Buchmann 2001 Ki-67 immunostaining in pancreatic cancer and chronic active pancreatitis: does in vivo FDG uptake correlate with proliferative activity? J Nucl Med 42 721 725 (Pubitemid 32453459)
18. C Guerra AJ Schuhmacher M Canamero PJ Grippo L Verdaguer L Perez-Gallego 2007 Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice Cancer Cell 11 291 302 (Pubitemid 46349841)
19. C Knoess S Siegel A Smith D Newport N Richerzhagen A Winkeler 2003 Performance evaluation of the microPET R4 PET scanner for rodents Eur J Nucl Med Mol Imaging 30 737 747 (Pubitemid 36612958)
20. Phelps ME, editor. PET molecular imaging and its biological applications. New York: Springer; 2004.
21. MC van Kouwen P Laverman JH van Krieken WJ Oyen JB Jansen JP Drenth 2005 FDG-PET in the detection of early pancreatic cancer in a BOP hamster model Nucl Med Biol 32 445 450 (Pubitemid 40854095)
22. T Higashi N Tamaki T Torizuka Y Nakamoto H Sakahara T Kimura 1998 FDG uptake, Glut-1 glucose transporter and cellularity in human pancreatic tumors J Nucl Med 39 1727 1735 (Pubitemid 28473521)
23. C von Forstner JH Egberts O Ammerpohl D Niedzielska R Buchert P Mikecz 2008 Gene expression patterns and tumor uptake of 18F-FDG, 18F-FLT, and 18F-FEC in PET/MRI of an orthotopic mouse xenotransplantation model of pancreatic cancer J Nucl Med 49 1362 1370
24. R Bos JJ van Der Hoeven E van Der Wall P van Der Groep PJ van Diest EF Comans 2002 Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography J Clin Oncol 20 379 387 (Pubitemid 34072519)
25. L Hooft AA van der Veldt PJ van Diest OS Hoekstra J Berkhof GJ Teule 2005 [18F]fluorodeoxyglucose uptake in recurrent thyroid cancer is related to hexokinase i expression in the primary tumor J Clin Endocrinol Metab 90 328 334 (Pubitemid 40116677)
26. M Natsuizaka M Ozasa S Darmanin M Miyamoto S Kondo S Kamada 2007 Synergistic up-regulation of Hexokinase-2, glucose transporters and angiogenic factors in pancreatic cancer cells by glucose deprivation and hypoxia Exp Cell Res 313 3337 3348 (Pubitemid 47284060)
27. DY Yoon P Buchler ST Saarikoski OJ Hines HA Reber O Hankinson 2001 Identification of genes differentially induced by hypoxia in pancreatic cancer cells Biochem Biophys Res Commun 288 882 886 (Pubitemid 33140965)
28. K Mikuriya Y Kuramitsu S Ryozawa M Fujimoto S Mori M Oka 2007 Expression of glycolytic enzymes is increased in pancreatic cancerous tissues as evidenced by proteomic profiling by two-dimensional electrophoresis and l quid chromatography-mass spectrometry/mass spectrometry Int J Oncol 30 849 855
29. SR Hingorani 2004 New pathways to pancreatic cancer Cancer Biol Ther 3 170 172 (Pubitemid 41350899)
30. RM Schmid 2002 Genetic basis of pancreatic cancer Best Pract Res Clin Gastroenterol 16 421 433
31. DA Tuveson SR Hingorani 2005 Ductal pancreatic cancer in humans and mice Cold Spring Harb Symp Quant Biol 70 65 72 (Pubitemid 44124857)
32. SR Hingorani EF Petricoin A Maitra V Rajapakse C King MA Jacobetz 2003 Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse Cancer Cell 4 437 450 (Pubitemid 38050041)
33. EU Nitzsche S Hoegerle M Mix I Brink A Otte E Moser 2002 Non-invasive differentiation of pancreatic lesions: is analysis of FDG kinetics superior to semiquantitative uptake value analysis? Eur J Nucl Med Mol Imaging 29 237 242
34. FX Real E Cibrián-Uhalte P Martinelli 2008 Pancreatic cancer development and progression: remodeling the model Gastroenterology 135 724 728